News

The committee voted in favor of separating MMR and chickenpox shots to lessen seizure risk, despite concerns doing so might ...
The purchase gives Biogen full access to an implantable device designed to help patients avoid the repeat lumbar punctures ...
T.Rx Capital was co-founded by Michael Langer, former Pear Therapeutics CEO Corey McMann and Eli Lilly veteran Kwesi Frimpong ...
A drug licensed from Pfizer will be submitted to the FDA next year after study results showed it reduced dermatomyositis ...
The British drugmaker’s commitment comes as some of its pharma peers question their U.K. presence amid a widening row there ...
A deal with Dutch startup VarmX gives CSL an option to buy a Phase 3-ready drug that could reverse the effects of popular ...
Susan Monarez told Senators at a hearing Wednesday that Robert F. Kennedy Jr. pushed her out for refusing to rubber-stamp ...
The company’s new partnership with the "molecular glue” drug developer is broad, focused on immunology and could be worth up ...
Backed by a trio of top venture firms, Ollin is working on a pair of medicines it believes can one-up Roche’s Vabysmo and ...
Thermal modeling uses heat transfer and fluid dynamics equations to estimate how temperature changes within a system over time. This simulation allows packaging designers to predict how a solution ...
HHS nominated five new members to ACIP ahead of a meeting Thursday and Friday that could prove an inflection point in HHS ...
The company’s market value was largely wiped out after a therapy it’s been developing for pulmonary sarcoidosis missed its ...